FDA 510(k) · GE Medical Systems Information Technologies

K234130: Portrait™ Mobile Monitoring Solution consists of: • Portrait™ Central Viewer Application (Portrait CVAXB) • Portrait™ Core Services (Portrait CSSXB) • Portrait™ Clinical Alarming Unit (Portrait CAU01) • Portrait™ Mobile Patient Monitor Hardware (Portrait HUBXB) • Portrait™ Mobile Patient Monitor Software (Portrait HSWXB) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SA01) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SP01) • Portrait™ Wearable Pulse O (Ge Medical Systems Information Technologies, Inc.)

Ge Medical Systems Information Technologies, Inc. received FDA 510(k) K234130 for Portrait™ Mobile Monitoring Solution consists of: • Portrait™ Central Viewer Application (Portrait CVAXB) • Portrait™ Core Services (Portrait CSSXB) • Portrait™ Clinical Alarming Unit (Portrait CAU01) • Portrait™ Mobile Patient Monitor Hardware (Portrait HUBXB) • Portrait™ Mobile Patient Monitor Software (Portrait HSWXB) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SA01) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SP01) • Portrait™ Wearable Pulse O, with a decision date of Mar 20, 2024 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K234130FDA summary or statement (PDF)

FDA facts

Official fields for K234130
FDA numberK234130
Pathway510(k)
ApplicantGe Medical Systems Information Technologies, Inc.
Device namePortrait™ Mobile Monitoring Solution consists of: • Portrait™ Central Viewer Application (Portrait CVAXB) • Portrait™ Core Services (Portrait CSSXB) • Portrait™ Clinical Alarming Unit (Portrait CAU01) • Portrait™ Mobile Patient Monitor Hardware (Portrait HUBXB) • Portrait™ Mobile Patient Monitor Software (Portrait HSWXB) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SA01) • Portrait™ Wearable Pulse Oximetry Sensor (Portrait SpO2 P-SP01) • Portrait™ Wearable Pulse O
Product codeMWI: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)
Regulation (21 CFR)870.2300
Device classClass 2
Date receivedDec 28, 2023
Decision dateMar 20, 2024
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

We could not extract the indications for this record. Check the FDA record for its summary or statement.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

  • K230626 Portrait™ Central Viewer Application (P… (GE Medical Systems Information Technologies)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code MWI is "Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)", class 2, 21 CFR 870.2300.

Our labels for filtering: claim SpO2 / pulse oximetry, sensor Unknown. These are heuristics, not FDA fields.